Condor Capital Management Ampio Pharmaceuticals, Inc. Transaction History

Condor Capital Management

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 01, 2018	SELL	$0.44 - $3.02 $9,416 - $64,628	-21,400 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$0.68 - $4.19 $14,552 - $89,666	21,400	21,400 $87,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

Stay updated on Condor Capital Management with notifications on news.